Restless legs-like syndrome as an emergent adverse event of CGRP monoclonal antibodies: A report of two cases.

AbstractBackgroundOne of the advantages of CGRP monoclonal antibodies is their excellent safety and tolerability. However, postmarketing surveillance, is essential to detect potential rare emergent...